Drokow Emmanuel Kwateng, Zi Liu, Han Qian, Effah Clement Yaw, Agboyibor Clement, Sasu Evans, Akpabla Gloria Selorm, Foli Francis, Sun Kai
Department of Radiation Oncology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital Henan, Zhengzhou, China.
Department of Radiation Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Front Oncol. 2020 Sep 8;10:1651. doi: 10.3389/fonc.2020.01651. eCollection 2020.
Cervical cancer (CC) is the fourth most commonly diagnosed cancer among women. Ghana is a low-middle- income country with annual diagnosed cases of 3,151 and 2,119 deaths. The high prevalence rate of cervical cancer in Ghana is mainly due to ineffective preventive measures and insufficient knowledge about the disease. Therefore, our objective was to evaluate the level of knowledge and awareness of cervical cancer and attitude toward human papillomavirus and its vaccine among Ghanaians. This descriptive cross-sectional survey on the awareness of cervical cancer and attitude toward human papillomavirus and its vaccine was carried out from March 2019 to February 2020. SPSS v. 23.0 was used in the data analysis. The participants' demographic characteristics, knowledge of cervical carcinoma, human papillomavirus vaccine and HPV, and the likelihood to be vaccinated were represented as percentages and frequencies. The difference between males and females was assessed using the chi-square test. The logistic regression analysis was used to evaluate the relationship of possible related indicators with the willingness to receive the HPV vaccine. A < 0.05 was considered statistically significant. A total of 1,376 participants were involved in the final analysis. Among the 1,376 participants involved in this survey, 1,240 participants (90.1%) representing 456 males (33.1%) and 784 females (57.0%) were aware of the terminology "cervical cancer" with a significant = 0.001. When stratified by gender, women had significantly greater knowledge, compared to men in terms of "cervical cancer being common in middle age (35-50) females" (75.5 vs. 67.5%, respectively, ≤ 0.001). When stratified by gender, women had significantly greater knowledge of human papillomavirus (54.5 vs. 43.6%, respectively, < 0.001) and the human papillomavirus vaccine (39.3 vs. 33.1%, respectively, = 0.019) compared to men. Majority of the respondents had poor knowledge regarding cervical cancer risk factors, symptoms, HPV, and its vaccine. Hence, this indicates a wakeup call for government to increase the awareness and knowledge level via the media and health professionals.
宫颈癌（CC）是女性中第四大最常被诊断出的癌症。加纳是一个中低收入国家，每年有3151例确诊病例和2119例死亡病例。加纳宫颈癌的高患病率主要是由于预防措施无效以及对该疾病的了解不足。因此，我们的目标是评估加纳人对宫颈癌的知识和认识水平以及对人乳头瘤病毒及其疫苗的态度。这项关于宫颈癌认识以及对人乳头瘤病毒及其疫苗态度的描述性横断面调查于2019年3月至2020年2月进行。数据分析使用了SPSS v. 23.0。参与者的人口统计学特征、对宫颈癌、人乳头瘤病毒疫苗和人乳头瘤病毒的了解以及接种疫苗的可能性以百分比和频率表示。使用卡方检验评估男性和女性之间的差异。逻辑回归分析用于评估可能相关指标与接受人乳头瘤病毒疫苗意愿之间的关系。P < 0.05被认为具有统计学意义。共有1376名参与者参与了最终分析。在参与此次调查的1376名参与者中，1240名参与者（90.1%）知晓“宫颈癌”这一术语，其中包括456名男性（33.1%）和784名女性（57.0%），差异具有统计学意义（P = 0.001）。按性别分层时，就“宫颈癌在中年（35 - 50岁）女性中常见”而言，女性的知晓率显著高于男性（分别为75.5%和67.5%，P ≤ 0.001）。按性别分层时，与男性相比，女性对人乳头瘤病毒（分别为54.5%和43.6%，P < 0.001）和人乳头瘤病毒疫苗（分别为39.3%和33.1%，P = 0.019）的了解明显更多。大多数受访者对宫颈癌的危险因素、症状、人乳头瘤病毒及其疫苗的了解较差。因此，这向政府敲响了警钟，需要通过媒体和卫生专业人员提高认识和知识水平。
